DOSING & ADMINISTRATION

PRESCRIBE BEVESPI AEROSPHERE

The BEVESPI AEROSPHERE inhaler is formulated with AEROSPHERE™ Delivery Technology The BEVESPI AEROSPHERE inhaler is formulated with AEROSPHERE™ Delivery Technology
  • Should be administered as 2 inhalations taken twice daily in the morning and in the evening

  • Do not use in combination with an additional medicine containing a LABA because of risk of overdose1

  • BEVESPI AEROSPHERE is NOT a rescue medication and does NOT replace fast-acting inhalers to treat acute symptoms

pMDI Device*…

  • Most commonly used inhaler in the US2†

  • Lower inspiratory flow requirement than a DPI3

  • Can be used with or without a spacer4

*The actual amount of a drug delivered to the lung may depend on patient factors, such as the coordination between actuation of the device and inspiration through the delivery system.

More than three-quarters of patients with COPD in the US filled a prescription for a pMDI medication (March 2016-February 2017).